Macopharma (UNEKLO USA, Inc. DBA Macopharma USA)

Macopharma, founded in 1977, is a major international player in blood processing and transfusion medicine. The company develops and manufactures a comprehensive range of blood processing solutions, combining disposables, equipment, software, and processing guidelines to support healthcare professionals in producing safer, higher-quality blood components. The company operates 3 manufacturing facilities across its global network of 15 subsidiaries serving 84 countries with approximately 1,911 employees. Macopharma specializes in blood component preparation, storage, and testing solutions, with documented expertise in red blood cell concentrate preservation (DEHT/PAGGSM and DEHP/SAGM containers), platelet processing (buffy coat-derived platelets), and hemolysis measurement methodologies. The company maintains active research and development collaborations focused on blood safety, cell therapy manufacturing supply chains, and sustainable blood industry practices. Products address blood bank operations, transfusion services, and cellular therapy manufacturing. The company emphasizes quality assurance, regulatory compliance, and environmental responsibility through documented CSR commitments and life cycle assessment initiatives. Macopharma's innovation framework (INNOV by Macopharma) involves cross-functional teams spanning R&D, Manufacturing, Medical Affairs, Marketing, Regulation, and Sales to develop solutions aligned with blood safety and sustainability standards.